PTEN and neoplasm: In addition, many signaling pathways are identified as predictive biomarkers for tumor sensitivity to ICB, e.g., chronic type I and type II interferon (IFN) signaling12, phosphatase and tensin homolog (PTEN)-related oncogenic pathways13, and oxidative stress-related metabolic processes14.